Menu

Avadel Pharmaceuticals plc AVDL

Full chart Compare
Set alert

Price alert · AVDL

All alert types
21.64 USD 0.00 (+0.00%)

Feb 13, 2026, 9:30 AM EST

21.64 Day range 21.64

52-week range unavailable

YTD
+0.42%
1 year
+140.71%

Revenue & Expenses

Other Income → Expenses: $4.15MIncome Tax Benefit → Expenses: $247.00KExpenses → Selling, General & Admin: $181.04MExpenses → Research & Development: $15.20MExpenses → Interest Expense: $10.83MGross Profit → Expenses: $153.84MRevenue → Gross Profit: $153.84MRevenue → Cost of Revenue: $15.28MNet Loss → Expenses: $48.83MOther Income$4.15MIncome Tax Benefit$247.00KGross Profit$153.84MNet Loss$48.83MCost of Revenue$15.28MExpenses$207.07MSelling, General & Admin$181.04MResearch & Development$15.20MInterest Expense$10.83MRevenue$169.12M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

AVDL annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
169.12M27.96M0022.33M
169.12M27.96M0022.33M
15.28M846.00K005.74M
153.84M27.12M0016.59M
196.24M164.97M98.56M85.55M7.45M
15.20M13.26M20.70M17.10M20.44M
181.04M151.71M74.52M68.50M32.41M
-42.40M-137.85M-98.56M-85.55M9.14M
10.83M9.89M12.34M9.94M12.99M
-247.00K-501.00K26.02M-15.82M-12.11M
-48.83M-160.28M-137.46M-77.33M7.03M
-48.83M-160.28M-137.46M-77.33M7.03M
-48.83M-160.28M-137.46M-77.33M7.03M
-48.83M-160.28M-137.46M-77.33M7.03M
-0.51-2.00-2.29-1.320.13
-0.51-2.00-2.29-1.320.13
-0.51-2.00-2.29-1.320.13
-38.25M-150.89M-99.10M-83.20M7.91M
-38.25M-150.89M-99.10M-83.20M7.91M
95.14M80.17M60.09M58.53M53.00M
95.14M80.17M60.09M58.53M54.94M